Athira Pharma’s experimental Alzheimer’s therapy, fosgonimeton, continues to show signs of being able to improve cognition and function in patients.
If you are not happy with the results below please do another search
50 search results for:
Adding to yesterday’s announcement of a $1.26 billion investment in Dublin, the company said it plans to match that investment to expand its Puurs, Belgium manufacturing site.
“We believe that subcutaneous formulation has the potential to be novel, non-obvious and useful, which means we would get a new patent for it,” according to Merck CFO Caroline Litchfield.
The company is developing brain chip interfaces that it says could help disabled patients to move and communicate again, with Musk adding it will also target restoring vision.
PictorLabs emerged from stealth mode Thursday with $15 million to advance its AI-powered virtual staining platform that researchers hope will “reimagine the future” of histopathology.
The investment to expand manufacturing at Pfizer’s plant in Dublin would double its capacity to produce key substances used in biological drugs.
The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to “persist” until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil.
Under the terms, biotech firm Roivant will be responsible for funding the development and will retain commercialization rights for RVT-3101, once approved, in the United States and Japan.
World AIDS Day on December 1 is an opportunity for people worldwide to unite in the fight against HIV and AIDS. It’s also time to take stock, be honest, and realize that we still have work to do to protect our communities.
The Ireland-based company issued a statement confirming that it is engaged in “highly preliminary discussions” with Amgen, Janssen, and Sanofi. Any acquisition of Horizon Therapeutics would be among the biggest deals of 2022.